Ranitim 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.
MFDS item code 201903777 · Approved 2019.06.07
This product's status changed to Expired on 2024.06.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related diseases (ulcers, esophagitis, etc.), improvement of gastric mucosal lesions, prevention of Mendelson syndrome
This medication is used to treat various gastrointestinal disorders such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing Mendelson's syndrome before anesthesia and treating ulcers post-surgery. Additionally, it aids in preventing and treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is also used to improve gastric mucosal lesions associated with acute exacerbations of acute gastritis, chronic gastritis, and upper gastrointestinal bleeding. This medication is effective in relieving symptoms of excessive stomach acid, heartburn, and acid reflux. Overall, it is used to protect the gastric mucosa and improve the symptoms of gastrointestinal diseases.
Administer ranitidine 150 mg per dose twice daily, orally in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg per dose twice daily orally, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent the development of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg per dose twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with this drug at 150 mg per dose 3 times daily and increase the dose as needed. For severe disease, up to 6 g daily may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration of this drug at 150 mg per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, adjust the dosing schedule to administer the drug immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
For patients aged 12 years or older, administer 75 mg per dose twice daily orally (liquid formulation only). For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.
This medication should not be used in patients with hypersensitivity to its ingredients. Patients with a history of acute porphyria should also not use this drug, as it may trigger acute attacks. It contains lactose, so it should not be administered to patients with lactose intolerance or related genetic issues. For patients with reduced kidney function, this medication may remain in the body longer, so dose adjustments or regimen modifications may be necessary. Patients with impaired liver function should also use this drug cautiously. Those with a history of drug hypersensitivity or elderly patients should be administered this medication with caution. Patients taking NSAIDs, especially the elderly or those with a history of peptic ulcers, require regular monitoring. It may mask symptoms of gastric cancer, so individuals over middle age with gastric ulcer or new or changed dyspeptic symptoms should confirm malignancy before use. Patients with gastric and duodenal ulcers positive for Helicobacter pylori should receive eradication therapy. This medication may rarely cause severe allergic reactions, such as anaphylactic shock, so if any abnormal symptoms occur during treatment, it should be discontinued immediately and managed accordingly. Symptoms of hypersensitivity such as hives, rash, and bronchospasm may also occur, requiring caution. Blood abnormalities, including fatigue, bleeding, and fever, may necessitate immediate medical evaluation. Rarely, liver dysfunction symptoms may occur, and use should be discontinued if jaundice or hepatitis symptoms appear. Cardiac rhythm disturbances, constipation, nausea, headache, dizziness, drowsiness, and confusion are also reported neurological abnormalities. Muscle pain, joint pain, and skin rashes may also rarely occur, so symptoms should be observed carefully. During treatment, monitor the course of the disease closely and use the minimum effective dose; if no effect is observed, it is advisable to switch to alternative therapy. Elderly patients, those with chronic lung disease, or diabetes mellitus face a heightened risk of pneumonia. Avoid driving or operating hazardous machinery in case of dizziness or drowsiness. This medication can affect the absorption or metabolism of other drugs, so dosage adjustments for concurrently taken medications may be necessary. In particular, the risk of bleeding is increased when taken with anticoagulants, thus regular blood tests to monitor status are essential. When taken with sucralfate, absorption may decrease, so a gap of at least 2 hours should be maintained between doses. The safety of this medication during pregnancy or lactation is not well established, so it should be used cautiously only when necessary. The safety for pediatric use has not been sufficiently confirmed, so caution is necessary. Elderly patients may have prolonged drug exposure due to decreased kidney function, necessitating dose reduction or increased dosing intervals. During treatment with this medication, false positives may appear in some urine tests, so be aware of the testing methods. No significant issues have been reported from overdose, but appropriate treatment, such as vomiting or gastric lavage, may be required. Store this medication out of reach of children, and do not transfer it to other containers, as this may compromise safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. It is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevent degradation.
White, round, film-coated tablet
Domestic use - 30 tablets - 30 tablets/bottle, Domestic use - 500 tablets - 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.